Efficacy of lactobacillus GG in decreasing antibiotic-associated gastrointestinal morbidity during H. pylori eradication regimen
1999-01-01 Armuzzi, A; Gasbarrini, A; Franceschi, F; Ojetti, V; Candelli, M; Torre, Es; Gabrielli, M; Di Campli, C; Carloni, E; Zocco, Ma; De Lorenzo, A; Gasbarrini, G
Usefulness of C-13-methionine breath test as a non-invasive and dynamic tool to evaluate residual hepatic mitochondrial function
1998-01-01 Gasbarrini, A; Armuzzi, A; Marcoccia, S; Grieco, A; Anti, M; Pola, P; Gasbarrini, G
Epithelial cell proliferation in gastric mucosa of Helicobacter pylori gastritis: Immunohistochemical study in a high gastric cancer risk population
1996-01-01 Baldini, L; Bonvicini, F; Epifanio, G; Pretolani, S; Fasanella, C; Cogliandro, L; Armuzzi, A; Miglio, F; Gasbarrini, G
INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS ON ANTI TNF-ALPHA THERAPY: RESPONSE TO THE INFLUENZA A/H1N1 VACCINE
2011-01-01 Andrisani, G; Frasca, D; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Mocci, G; Pugliese, D; Vitale, G; De Vitis, I; Rapaccini, Gl; Guidi, L
Long-Term Scheduled Therapy with Infliximab in Inflammatory Bowel Disease
2009-01-01 Armuzzi, A; De Vincentis, F; Marzo, M; Mocci, G; Felice, C; Fedeli, P; De Vitis, I; Papa, A; Gasbarrini, A; Guidi, L
Efficacy and Safety of Low-Molecular Weight Heparin for the Prevention of Venous Thromboembolism in Patients With Severe Ulcerative Colitis
2012-01-01 Papa, A; Armuzzi, A; Guidi, L; Marzo, M; Felice, C; Andrisani, G; Mocci, G; Pugliese, D; De Vitis, I; Gasbarrini, A; Rapaccini, Gl
Role of the HLA in determining susceptibility and phenotype in Caucasian ulcerative colitis (LIC)
2002-01-01 Ahmad, T; Armuzzi, A; Bunce, M; Mulcahy-Hawes, K; Crawshaw, J; Large, O; Welsh, K; Jewell, D
Comparison of different probiotic supplementations for preventing side effects of a standard anti-H-pylori scheme: A randomized, double-blind, placebo-controlled study
2001-01-01 Cremonini, F; Di Caro, S; Armuzzi, A; Gabrielli, M; Candelli, M; Nista, E; Lupascu, A; Rapaccini, G; Gasbarrini, G; Gasbarrini, A
DOES ANTI-TNF ALPHA TREATMENT INCREASE SHORT-TERM POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? AN ITALIAN SINGLE CENTER EXPERIENCE
2010-01-01 Rizzo, G; Armuzzi, A; Mattana, C; Pugliese, D; Verbo, A; Guidi, L; Manno, A; Andrisani, G; Papa, A; De Vitis, I; Rapaccini, G; Coco, C
Incidence and symptoms related to Helicobacter pylori infection in patients with headache
1997-01-01 Deluca, A; Gasbarrini, A; Fiore, G; Ojetti, V; Franceschi, F; Dicampli, C; Candelli, M; Armuzzi, A; Anti, M; Pola, P; Giacovazzo, M; Gasbarrini, G
Prevention of Postoperative Recurrence With Azathioprine or Anti-TNF Alpha in Patients With Crohn's Disease: an Open-Label Pilot Study
2012-01-01 Armuzzi, A; Felice, C; Marzo, M; Pugliese, D; Andrisani, G; Papa, A; De Vitis, I; Rapaccini, Gl; Guidi, L
Methionine breath test to assess mithocondrial liver function after orthotopic liver transplantation
2001-01-01 Angelini, G; Candelli, M; Nardo, B; Di Campli, G; Armuzzi, A; Zocco, Ma; Nista, Ec; Bernardi, M; Gasbarrini, G; Cavallari, A; Gasbarrini, A
Influence of Lactobacillus GG supplementation on anti-H-pylori therapy-related side effects
2000-01-01 Cremonini, F; Armuzzi, A; Gabrielli, M; Torre, Es; Carloni, E; Padalino, C; Gasbarrini, Gb; Gasbarrini, A
Hepatic mitochondrial function assessment through 13C-methionine, 13C-octanoate and 13C-ketoisocaproate breath tests
2001-01-01 Candelli, M; Armuzzi, A; Zocco, Ma; Nista, Ec; De Lorenzo, A; Grieco, A; Miele, L; Di Caro, S; Gasbarrini, G; Gasbarrini, A
Helicobacter pylori infection and multiple myeloma: Is there a link?
2000-01-01 Candelli, M; De Stefano, V; Di Mario, A; Danese, S; Armuzzi, A; Cremonini, F; Pola, P; Leone, G; Gasbarrini, Gb; Gasbarrini, A
Incidence and symptoms related to Helicobacter pylori infection in dyspeptic patients
1997-01-01 Gasbarrini, A; Deluca, A; Ojetti, V; Franceschi, F; Candelli, M; Dicampli, C; Armuzzi, A; Anti, M; Fedeli, G; Pola, P; Gasbarrini, G
Apoptosis and cell proliferation along the entire colonic mucosa in subjects at risk for colorectal cancer
1997-01-01 Anti, M; Iascone, E; Morini, S; Armuzzi, A; Pignataro, G; Lorenzetti, R; Valenti, A; Covino, M; Lippi, Me; Vecchio, Fm; Canetta, C; Coco, C; Gasbarrini, G
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients who are primary non-responders or intolerant to infliximab: A real life multi-center experience of compassionate use
2008-01-01 Danese, S; Mocciaro, F; Guidi, L; Scribano, Ml; Comberlato, M; Vangeli, M; Pulitano, R; Manca, A; Armuzzi, A; Malesci, A; Prantera, C; Cottone, M
C-13 urea breath test for predicting resistance to therapy in Helicobacter pylori infection
2000-01-01 Cremonini, F; Zocco, Ma; Armuzzi, A; Bartolozzi, F; Santarelli, L; Ojetti, V; Candelli, M; Gabrielli, M; Nista, E; Canducci, F; Sanz-Torre, E; Cammarota, G; Anti, M; Gasbarrini, G; Gasbarrini, A
Lack of efficacy of a levofloxacin-based dual therapy for H-pylori eradication
2001-01-01 Di Caro, S; Zocco, Ma; Cremonini, F; Armuzzi, A; Candelli, M; Torre, Hs; Nista, Ec; Carloni, E; Gasbarrini, G; Gasbarrini, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Efficacy of lactobacillus GG in decreasing antibiotic-associated gastrointestinal morbidity during H. pylori eradication regimen | 1-gen-1999 | Armuzzi, A; Gasbarrini, A; Franceschi, F; Ojetti, V; Candelli, M; Torre, Es; Gabrielli, M; Di Campli, C; Carloni, E; Zocco, Ma; De Lorenzo, A; Gasbarrini, G | |
| Usefulness of C-13-methionine breath test as a non-invasive and dynamic tool to evaluate residual hepatic mitochondrial function | 1-gen-1998 | Gasbarrini, A; Armuzzi, A; Marcoccia, S; Grieco, A; Anti, M; Pola, P; Gasbarrini, G | |
| Epithelial cell proliferation in gastric mucosa of Helicobacter pylori gastritis: Immunohistochemical study in a high gastric cancer risk population | 1-gen-1996 | Baldini, L; Bonvicini, F; Epifanio, G; Pretolani, S; Fasanella, C; Cogliandro, L; Armuzzi, A; Miglio, F; Gasbarrini, G | |
| INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS ON ANTI TNF-ALPHA THERAPY: RESPONSE TO THE INFLUENZA A/H1N1 VACCINE | 1-gen-2011 | Andrisani, G; Frasca, D; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Mocci, G; Pugliese, D; Vitale, G; De Vitis, I; Rapaccini, Gl; Guidi, L | |
| Long-Term Scheduled Therapy with Infliximab in Inflammatory Bowel Disease | 1-gen-2009 | Armuzzi, A; De Vincentis, F; Marzo, M; Mocci, G; Felice, C; Fedeli, P; De Vitis, I; Papa, A; Gasbarrini, A; Guidi, L | |
| Efficacy and Safety of Low-Molecular Weight Heparin for the Prevention of Venous Thromboembolism in Patients With Severe Ulcerative Colitis | 1-gen-2012 | Papa, A; Armuzzi, A; Guidi, L; Marzo, M; Felice, C; Andrisani, G; Mocci, G; Pugliese, D; De Vitis, I; Gasbarrini, A; Rapaccini, Gl | |
| Role of the HLA in determining susceptibility and phenotype in Caucasian ulcerative colitis (LIC) | 1-gen-2002 | Ahmad, T; Armuzzi, A; Bunce, M; Mulcahy-Hawes, K; Crawshaw, J; Large, O; Welsh, K; Jewell, D | |
| Comparison of different probiotic supplementations for preventing side effects of a standard anti-H-pylori scheme: A randomized, double-blind, placebo-controlled study | 1-gen-2001 | Cremonini, F; Di Caro, S; Armuzzi, A; Gabrielli, M; Candelli, M; Nista, E; Lupascu, A; Rapaccini, G; Gasbarrini, G; Gasbarrini, A | |
| DOES ANTI-TNF ALPHA TREATMENT INCREASE SHORT-TERM POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? AN ITALIAN SINGLE CENTER EXPERIENCE | 1-gen-2010 | Rizzo, G; Armuzzi, A; Mattana, C; Pugliese, D; Verbo, A; Guidi, L; Manno, A; Andrisani, G; Papa, A; De Vitis, I; Rapaccini, G; Coco, C | |
| Incidence and symptoms related to Helicobacter pylori infection in patients with headache | 1-gen-1997 | Deluca, A; Gasbarrini, A; Fiore, G; Ojetti, V; Franceschi, F; Dicampli, C; Candelli, M; Armuzzi, A; Anti, M; Pola, P; Giacovazzo, M; Gasbarrini, G | |
| Prevention of Postoperative Recurrence With Azathioprine or Anti-TNF Alpha in Patients With Crohn's Disease: an Open-Label Pilot Study | 1-gen-2012 | Armuzzi, A; Felice, C; Marzo, M; Pugliese, D; Andrisani, G; Papa, A; De Vitis, I; Rapaccini, Gl; Guidi, L | |
| Methionine breath test to assess mithocondrial liver function after orthotopic liver transplantation | 1-gen-2001 | Angelini, G; Candelli, M; Nardo, B; Di Campli, G; Armuzzi, A; Zocco, Ma; Nista, Ec; Bernardi, M; Gasbarrini, G; Cavallari, A; Gasbarrini, A | |
| Influence of Lactobacillus GG supplementation on anti-H-pylori therapy-related side effects | 1-gen-2000 | Cremonini, F; Armuzzi, A; Gabrielli, M; Torre, Es; Carloni, E; Padalino, C; Gasbarrini, Gb; Gasbarrini, A | |
| Hepatic mitochondrial function assessment through 13C-methionine, 13C-octanoate and 13C-ketoisocaproate breath tests | 1-gen-2001 | Candelli, M; Armuzzi, A; Zocco, Ma; Nista, Ec; De Lorenzo, A; Grieco, A; Miele, L; Di Caro, S; Gasbarrini, G; Gasbarrini, A | |
| Helicobacter pylori infection and multiple myeloma: Is there a link? | 1-gen-2000 | Candelli, M; De Stefano, V; Di Mario, A; Danese, S; Armuzzi, A; Cremonini, F; Pola, P; Leone, G; Gasbarrini, Gb; Gasbarrini, A | |
| Incidence and symptoms related to Helicobacter pylori infection in dyspeptic patients | 1-gen-1997 | Gasbarrini, A; Deluca, A; Ojetti, V; Franceschi, F; Candelli, M; Dicampli, C; Armuzzi, A; Anti, M; Fedeli, G; Pola, P; Gasbarrini, G | |
| Apoptosis and cell proliferation along the entire colonic mucosa in subjects at risk for colorectal cancer | 1-gen-1997 | Anti, M; Iascone, E; Morini, S; Armuzzi, A; Pignataro, G; Lorenzetti, R; Valenti, A; Covino, M; Lippi, Me; Vecchio, Fm; Canetta, C; Coco, C; Gasbarrini, G | |
| Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients who are primary non-responders or intolerant to infliximab: A real life multi-center experience of compassionate use | 1-gen-2008 | Danese, S; Mocciaro, F; Guidi, L; Scribano, Ml; Comberlato, M; Vangeli, M; Pulitano, R; Manca, A; Armuzzi, A; Malesci, A; Prantera, C; Cottone, M | |
| C-13 urea breath test for predicting resistance to therapy in Helicobacter pylori infection | 1-gen-2000 | Cremonini, F; Zocco, Ma; Armuzzi, A; Bartolozzi, F; Santarelli, L; Ojetti, V; Candelli, M; Gabrielli, M; Nista, E; Canducci, F; Sanz-Torre, E; Cammarota, G; Anti, M; Gasbarrini, G; Gasbarrini, A | |
| Lack of efficacy of a levofloxacin-based dual therapy for H-pylori eradication | 1-gen-2001 | Di Caro, S; Zocco, Ma; Cremonini, F; Armuzzi, A; Candelli, M; Torre, Hs; Nista, Ec; Carloni, E; Gasbarrini, G; Gasbarrini, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2151
Data di pubblicazione
- 2020 - 2026113
- 2010 - 20191340
- 2000 - 2009587
- 1990 - 1999110
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...120
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng794
- ita24
- und6
Accesso al fulltext
- no fulltext2098
- reserved51
- open2